China Southern Airlines Company Limited - 1055.HK

1055.HK Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
1055.HK	0	7.0	-5.7	28.2	38.5	29.4	-20.3	-21.9	3.9	243.4
S&P 500	1.0	3.7	2.2	2.3	8.9	23.9	32.3	80.6	196.5	33856.2

Compare 1055.HK with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	1055.HK
name	China Southern Airlines Company Limited
price	3.96
changes percentage	0
change	0
day low	3.84
day high	3.98
year high	4.42
year low	2.36
market cap	110632272712
price avg 50	3.8476
price avg 200	3.16675
exchange	HKSE
volume	5780000
avg volume	18023052
open	3.96
previous close	3.96
eps	-0.2
pe	-19.8
earnings announcement	2025-03-25T10:59:00.000+0000
shares outstanding	27937442604
timestamp	2025-01-17 08:08:13

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 50.3%

Overall Quarterly Financial Health: 70.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	159929000000	87059000000	83.70
gross profit	12347000000	-17178000000	171.88
gross profit ratio	0.08	-0.2	139.13
research and development expenses	511000000	389000000	31.36
operating expenses	14489000000	5888000000	146.08
interest income	222000000	457000000	-51.42
interest expense	2328000000	6006000000	-61.24
ebitda	27693000000	-5357000000	616.95
ebitdaratio	0.17	-0.25	169.65
operating income	-2142000000	-22542000000	90.50
operating income ratio	-0.01	-0.26	94.83
net income	-4209000000	-33716000000	87.52
net income ratio	-0.03	-0.39	93.20
eps	-0.23	-1.96	88.27

Overall Score of Annual Income Statement

0.75 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 159,929 million in 2023 from 87,059 million in 2022 representing a change of 83.7%. This indicates a sales shrinking, which is a negative sign for the company.

  Operating Income: Operating income decreased to -2,142 million in 2023 from -22,542 million in 2022 representing a change of 90.5%. The decrease in operating income indicates worse operational performance and decreased profitability.

• 📈 Positive Indicators

  Gross Profit: Gross Profit increased to 12,347 million in 2023 from -17,178 million in 2022 representing a change of 171.88%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 511 million in 2023 from 389 million in 2022 representing a change of 31.36%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Expenses: Operating Expenses decreased to 14,489 million in 2023 from 5,888 million in 2022 representing a change of 146.08%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 27,693 million in 2023 from -5,357 million in 2022 representing a change of 616.95%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Net Income: Net income increased to -4,209 million in 2023 from -33,716 million in 2022 representing a change of 87.52%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to -0.23 in 2023 from -0.23 in 2022 representing a change of 88.27%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
revenue	49871000000	40189000000	24.09
gross profit	7684000000	1363000000	463.76
gross profit ratio	0.15	0.03	354.31
research and development expenses	133000000	113000000	17.70
operating expenses	3087000000	2002000000	54.20
interest income	60000000	33000000	81.82
interest expense	3072000000	1430000000	114.83
ebitda	7868000000	-221000000	3660.18
ebitdaratio	0.16	-0.01	2969.00
operating income	4597000000	-3385000000	235.81
operating income ratio	0.09	-0.08	209.44
net income	3193000000	-1984000000	260.94
net income ratio	0.06	-0.05	229.69
eps	0.18	-0.11	263.64

Overall Score of Quarterly Income Statement

0.88 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 49,871 million in 2024Q3 from 40,189 million in 2024Q2 representing a change of 24.09%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 7,684 million in 2024Q3 from 1,363 million in 2024Q2 representing a change of 463.76%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 133 million in 2024Q3 from 113 million in 2024Q2 representing a change of 17.7%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 7,868 million in 2024Q3 from -221 million in 2024Q2 representing a change of 3660.18%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 4,597 million in 2024Q3 from -3,385 million in 2024Q2 representing a change of 235.81%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 3,193 million in 2024Q3 from -1,984 million in 2024Q2 representing a change of 260.94%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.18 in 2024Q3 from 0.18 in 2024Q2 representing a change of 263.64%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 3,087 million in 2024Q3 from 2,002 million in 2024Q2 representing a change of 54.2%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	309226000000	312246000000	-0.97
total liabilities	257229000000	256887000000	0.13
total equity	51997000000	55359000000	-6.07
cash and cash equivalents	9924000000	19889000000	-50.10
short term investments	3157000000	2000000	157750.00
long term investments	10387000000	7301000000	42.27
total current assets	27741000000	33454000000	-17.08
total non current assets	281485000000	278792000000	0.97
total current liabilities	129436000000	141458000000	-8.50
total non current liabilities	127793000000	115429000000	10.71
common stock	18121000000	18121000000	0.00
retained earnings	-34309000000	-30100000000	-13.98
total debt	171116000000	214542000000	-20.24

Overall Score of Annual Balance Sheet

0.33 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 309,226 million in 2023 from 312,246 million in 2022 representing a change of -0.97%. Suggesting a decrease in asset holdings.

  Total Liabilities: Total Liabilities increased to 257,229 million in 2023 from 256,887 million in 2022 representing a change of 0.13%. This indicates an increase in overall liabilities.

  Total Equity: Total Equity decreased to 51,997 million in 2023 from 55,359 million in 2022 representing a change of -6.07%. This indicates a decrease in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 9,924 million in 2023 from 19,889 million in 2022 representing a change of -50.1%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 27,741 million in 2023 from 33,454 million in 2022 representing a change of -17.08%. This indicates a worsen liquidity position.

  Retained Earnings: Retained Earnings decreased to -34,309 million in 2023 from -30,100 million in 2022 representing a change of -13.98%. This indicates an accumulated losses.

• 📈 Positive Indicators

  Short Term Investments: Short Term Investments increased to 3,157 million in 2023 from 2 million in 2022 representing a change of 157750.0%. This indicates an increase in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities decreased to 129,436 million in 2023 from 141,458 million in 2022 representing a change of -8.5%. This indicates a lower short-term debt burden.

  Total Debt: Total Debt decreased to 171,116 million in 2023 from 214,542 million in 2022 representing a change of -20.24%. This indicates a reduction in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
total assets	315952000000	314935000000	0.32
total liabilities	260396000000	263589000000	-1.21
total equity	55556000000	51346000000	8.20
cash and cash equivalents	11535000000	11425000000	0.96
short term investments	2628000000	2699000000	-2.63
long term investments	7815000000	7555000000	3.44
total current assets	32034000000	31992000000	0.13
total non current assets	283918000000	282943000000	0.34
total current liabilities	136344000000	140253000000	-2.79
total non current liabilities	124052000000	123336000000	0.58
common stock	18121000000	18121000000	0.00
retained earnings	-34923000000	-38116000000	8.38
total debt	156852000000	201448000000	-22.14

Overall Score of Quarterly Balance Sheet

0.89 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 315,952 million in 2024Q3 from 314,935 million in 2024Q2 representing a change of 0.32%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 260,396 million in 2024Q3 from 263,589 million in 2024Q2 representing a change of -1.21%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 55,556 million in 2024Q3 from 51,346 million in 2024Q2 representing a change of 8.2%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 11,535 million in 2024Q3 from 11,425 million in 2024Q2 representing a change of 0.96%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 32,034 million in 2024Q3 from 31,992 million in 2024Q2 representing a change of 0.13%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 136,344 million in 2024Q3 from 140,253 million in 2024Q2 representing a change of -2.79%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to -34,923 million in 2024Q3 from -38,116 million in 2024Q2 representing a change of 8.38%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 156,852 million in 2024Q3 from 201,448 million in 2024Q2 representing a change of -22.14%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Short Term Investments: Short Term Investments decreased to 2,628 million in 2024Q3 from 2,699 million in 2024Q2 representing a change of -2.63%. This indicates a decrease in short-term investment holdings.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	-10358000000	-1567000000	-561.01
operating cash flow	40134000000	-2450000000	1738.12
free cash flow	28765000000	-14146000000	303.34
capital expenditure	-11369000000	-11696000000	2.80
depreciation and amortization	27010000000	24266000000	11.31
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts payables	1770000000	-1434000000	223.43
inventory	-186000000	187000000	-199.47
acquisitions net	0	857000000	-100.00
investments in property plant and equipment	-11369000000	-11696000000	2.80
net cash used for investing activites	-17511000000	-5851000000	-199.28
debt repayment	-26630000000	1410000000	-1988.65
common stock issued	0	6046000000	-100.00
common stock repurchased	0	0	NaN
dividends paid	-6444000000	-6359000000	-1.34
net cash used provided by financing activities	-33006000000	299000000	-11138.80
cash at end of period	9531000000	19889000000	-52.08
accounts receivables	-1770000000	1434000000	-223.43
cash at beginning of period	19889000000	21456000000	-7.30

Overall Score of Annual Cashflow Statement

0.43 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -10,358 million in 2023 from -1,567 million in 2022 representing a change of -561.01%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure increased to -11,369 million in 2023 from -11,696 million in 2022 representing a change of 2.8%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Payables: The absolute value of Accounts Payables increased to 1,770 million in 2023 from 1,434 million in 2022 representing a change of 223.43%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Dividends Paid: Dividends Paid decreased to -6,444 million in 2023 from -6,359 million in 2022 representing a change of -1.34%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• 📈 Positive Indicators

  Operating Cash Flow: Operating Cash Flow increased to 40,134 million in 2023 from -2,450 million in 2022 representing a change of 1738.12%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 28,765 million in 2023 from -14,146 million in 2022 representing a change of 303.34%. This indicates an increase in cash generated after accounting for capital expenditures.

  Accounts Receivables: Accounts Receivables decreased to -1,770 million in 2023 from 1,434 million in 2022 representing a change of -223.43%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
operating cash flow	0	5933000000	-100.00
free cash flow	-1312000000	720000000	-282.22
capital expenditure	-1312000000	-5213000000	74.83
depreciation and amortization	0	13955000000	-100.00
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	0	-2737000000	100.00
accounts payables	0	0	NaN
inventory	0	-223000000	100.00
acquisitions net	0	0	NaN
investments in property plant and equipment	-1312000000	-5213000000	74.83
net cash used for investing activites	-937000000	-6026000000	84.45
debt repayment	-27245000000	2941000000	-1026.39
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-1394000000	-1485000000	6.13
net cash used provided by financing activities	-10230000000	-37000000	-27548.65
net change in cash	-39000000	-139000000	71.94
cash at end of period	9514000000	9553000000	-0.41
cash at beginning of period	9553000000	9692000000	-1.43

Overall Score of Quarterly Cashflow Statement

0.33 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to -39 million in 2024Q3 from -139 million in 2024Q2 representing a change of 71.94%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Dividends Paid: Dividends Paid increased to -1,394 million in 2024Q3 from -1,485 million in 2024Q2 representing a change of 6.13%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 0 million in 2024Q3 from 5,933 million in 2024Q2 representing a change of -100.0%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to -1,312 million in 2024Q3 from 720 million in 2024Q2 representing a change of -282.22%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to -1,312 million in 2024Q3 from -5,213 million in 2024Q2 representing a change of 74.83%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Receivables: Accounts Receivables increased to 0 in 2024Q3 from -2,737 million in 2024Q2 representing a change of 100.0%. This suggests that the company is less capable of collecting payments from its customers.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	8.74	5.06	72.71
net income per share	-0.23	-1.96	88.26
operating cash flow per share	2.19	-0.14	1640.10
free cash flow per share	1.57	-0.82	291.18
cash per share	0.71	1.16	-38.17
book value per share	2.84	3.22	-11.69
tangible book value per share	2.48	2.89	-14.08
shareholders equity per share	2.01	2.4	-16.21
interest debt per share	11.34	12.82	-11.52
market cap	105225000000	130758000000	-19.53
enterprise value	300535000000	325411000000	-7.64
pe ratio	-25	-3.88	-544.63
price to sales ratio	0.66	1.5	-56.19
pocfratio	2.62	-53.37	104.91
pfcf ratio	3.66	-9.24	139.57
pb ratio	2.86	3.17	-9.70
ptb ratio	2.86	3.17	-9.70
ev to sales	1.88	3.74	-49.73
enterprise value over ebitda	10.85	-60.75	117.87
ev to operating cash flow	7.49	-132.82	105.64
ev to free cash flow	10.45	-23.0	145.42
earnings yield	-0.04	-0.26	84.49
free cash flow yield	0.27	-0.11	352.69
debt to equity	5.58	5.2	7.34
debt to assets	0.66	0.69	-3.40
net debt to ebitda	7.05	-36.34	119.41
current ratio	0.21	0.24	-9.38
interest coverage	-0.92	-3.75	75.49
income quality	-9.54	0.08	-12379.11
dividend yield	0.06	0.05	25.93
payout ratio	-1.53	-0.19	-711.75
sales general and administrative to revenue	0.01	0.04	-87.60
research and ddevelopement to revenue	0.0	0.0	-28.12
intangibles to total assets	0.02	0.02	17.06
capex to operating cash flow	0.28	-4.77	105.93
capex to revenue	0.07	0.13	-47.09
capex to depreciation	0.42	0.48	-13.22
stock based compensation to revenue	0	0	NaN
graham number	3.23	10.28	-68.64
roic	-0.02	-0.09	82.46
return on tangible assets	-0.01	-0.11	87.35
graham net net	-13.09	-13.53	3.25
working capital	-101695000000	-108004000000	5.84
tangible asset value	45368000000	49641000000	-8.61
net current asset value	-229488000000	-223433000000	-2.71
invested capital	154340000000	148017000000	4.27
average receivables	4947500000	4531000000	9.19
average payables	8420500000	13267000000	-36.53
average inventory	1476000000	1519500000	-2.86
days sales outstanding	11.74	19.92	-41.06
days payables outstanding	6.16	50.25	-87.75
days of inventory on hand	3.87	4.86	-20.31
receivables turnover	31.09	18.32	69.67
payables turnover	59.27	7.26	716.05
inventory turnover	94.31	75.15	25.49
roe	-0.11	-0.82	85.99
capex per share	0.62	0.68	-8.61

• Negative

  ROE: Return on Equity (ROE) increased to -0.11 on 2023-12-31 from -0.82 on 2022-12-31, representing a change of 85.99%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -25.00 on 2023-12-31 from -3.88 on 2022-12-31, representing a change of -544.63%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio decreased to 0.21 on 2023-12-31 from 0.24 on 2022-12-31, representing a change of -9.38%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Also, it's below 1, indicating potential liquidity issues.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 5.58 on 2023-12-31 from 5.20 on 2022-12-31, representing a change of 7.34%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. A ratio of 2.0 or higher is usually considered risky.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
1055.HK
calendar year	2024	2024	NaN
revenue per share	2.75	2.21	24.54
net income per share	0.18	-0.11	260.94
operating cash flow per share	0.62	0.34	79.50
free cash flow per share	0.54	0.06	853.93
cash per share	0.78	0.78	0.28
book value per share	3.07	2.86	7.37
tangible book value per share	2.69	2.47	8.84
shareholders equity per share	2.13	1.96	9.00
interest debt per share	8.83	11.68	-24.42
market cap	118510741106.04	106369728832.96	11.41
enterprise value	263827741106.04	305117728832.96	-13.53
pe ratio	9.28	-13.4	169.23
price to sales ratio	2.38	2.66	-10.54
pocfratio	10.57	17.04	-37.93
pfcf ratio	12.05	103.17	-88.32
pb ratio	3.06	3.0	2.22
ptb ratio	3.06	3.0	2.22
ev to sales	5.29	7.62	-30.57
enterprise value over ebitda	43.67	-186.16	123.46
ev to operating cash flow	23.54	48.87	-51.83
ev to free cash flow	26.83	295.94	-90.94
earnings yield	0.03	-0.02	244.45
free cash flow yield	0.08	0.01	756.20
debt to equity	4.06	5.92	-31.53
debt to assets	0.5	0.63	-21.01
net debt to ebitda	24.06	-121.26	119.84
current ratio	0.23	0.23	3.00
interest coverage	1.5	-1.1	235.95
income quality	3.51	-3.15	211.53
dividend yield	0.01	0.01	-15.74
payout ratio	0.44	-0.75	158.33
sales general and administrative to revenue	0.05	0.02	120.71
research and ddevelopement to revenue	0.0	0.0	-4.65
intangibles to total assets	0.02	0.02	3.66
capex to operating cash flow	0.12	0.83	-85.98
capex to revenue	0.03	0.13	-79.79
capex to depreciation	0	0.75	-100.00
stock based compensation to revenue	0	0	NaN
graham number	2.91	2.2	32.45
roic	0.02	-0.01	217.43
return on tangible assets	0.01	-0.01	270.47
graham net net	-13.22	-14.56	9.20
working capital	-104310000000	-108261000000	3.65
tangible asset value	48702000000	44746000000	8.84
net current asset value	-228362000000	-250675000000	8.90
invested capital	153300000000	149434000000	2.59
average receivables	6304000000	4855000000	29.85
average payables	21154000000	22038500000	-4.01
average inventory	1887500000	1793000000	5.27
days sales outstanding	13.62	11.37	19.82
days payables outstanding	44.06	50.03	-11.93
days of inventory on hand	4.24	4.13	2.63
receivables turnover	6.61	7.92	-16.54
payables turnover	2.04	1.8	13.55
inventory turnover	21.23	21.79	-2.56
roe	0.08	-0.06	247.65
capex per share	0.07	0.29	-74.83

• ROE:

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 9.28 on 2024-09-30 Q3 from -13.40 on 2024-06-30 Q2, representing a change of 169.23%. Indicating an increase in the relative valuation of the company's stock.

• Negative

  Current Ratio: Current Ratio decreased to 0.23 on 2024-09-30 Q3 from 0.23 on 2024-06-30 Q2, representing a change of 3.00%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Also, it's below 1, indicating potential liquidity issues.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 4.06 on 2024-09-30 Q3 from 5.92 on 2024-06-30 Q2, representing a change of -31.53%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. However, a ratio of 2.0 or higher is usually considered risky.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None